Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Products
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Mode of Purchase
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Technology
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Sample Type
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on End-users
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region
North America Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Europe Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Asia Pacific Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Latin America Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Billion) by Country
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Point of Care Diagnostics Market Snapshot
Chapter 4. Global Point of Care Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Point of Care Diagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on POINT OF CARE DIAGNOSTICS MARKET Industry Trends
Chapter 5. Point of Care Diagnostics Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share by Products, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products:
5.2.1. Glucose Monitoring Products
5.2.1.1. Glucose Monitoring Strips
5.2.1.2. Glucose Monitoring Meters
5.2.1.3. Glucose Monitoring Lancets & Lancing Devices
5.2.2. Cardiometabolic Monitoring Products
5.2.2.1. Cardiac Marker Testing Products
5.2.2.2. Blood Gas/Electrolyte Testing Products
5.2.2.3. HbA1c Testing Products
5.2.3. Infectious Disease Testing Products
5.2.3.1. Respiratory Infection Testing Products
5.2.3.1.1. Influenza Testing Products
5.2.3.1.2. Tuberculosis
5.2.3.1.3. Other Respiratory Infections
5.2.3.2. Healthcare-Associated Infection Testing Products
5.2.3.3. Tropical Disease Testing Products
5.2.3.4. Sexually Transmitted Disease Testing Products
5.2.3.4.1. HIV Testing Products
5.2.3.4.2. Hepatitis Testing Products
5.2.3.4.3. Syphilis Testing Products
5.2.3.4.4. Human Papillomavirus Testing Products
5.2.3.4.5. Chlamydia trachomatis Testing Products
5.2.3.4.6. Neisseria gonorrhoeae Testing Products
5.2.3.4.7. Herpes Simplex Virus Testing Products
5.2.3.5. Clostridium difficile Infection Testing Products
5.2.3.6. Other Infectious Disease Testing Products
5.2.4. Coagulation Monitoring Products
5.2.4.1. PT/INR Testing Products
5.2.4.2. ACT/APTT Testing Products
5.2.5. Pregnancy & Fertility Testing Products
5.2.5.1. Pregnancy Testing Products
5.2.5.2. Fertility Testing Products
5.2.6. Tumor/Cancer Marker Testing Products
5.2.7. Urinalysis Testing Products
5.2.8. Cholesterol Testing Products
5.2.9. Hematology Testing Products
5.2.10. Drugs-of-Abuse Testing Products
5.2.11. Thyroid-Stimulating Hormone Testing Products
5.2.12. Fecal Occult Testing Products
5.2.13. Other Products
Chapter 6. Point of Care Diagnostics Market Segmentation 2: By Mode of Purchase, Estimates & Trend Analysis
6.1. Market Share by Mode of Purchase, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Mode of Purchase:
6.2.1. Prescription-Based Testing Products
6.2.2. Over-the-Counter (OTC) Testing Product
Chapter 7. Point of Care Diagnostics Market Segmentation 3: By Technology, Estimates & Trend Analysis
7.1. Market Share by Technology, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
7.2.1. Biochemistry
7.2.2. Immunoassays
7.2.3. Molecular Diagnostics
7.2.3.1. RT-PCR
7.2.3.2. INAAT
Chapter 8. Point of Care Diagnostics Market Segmentation 4: By Sample Type, Estimates & Trend Analysis
8.1. Market Share by Sample Type, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sample Type:
8.2.1. Blood Samples
8.2.2. Nasal & Oropharyngeal Swabs
8.2.3. Urine Samples
8.2.4. Other Samples
Chapter 9. Point of Care Diagnostics Market Segmentation 5: By End-users, Estimates & Trend Analysis
9.1. Market Share by End-users, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-users:
9.2.1. Home Care/Self Testing
9.2.2. Physician offices & Outpatient/Ambulatory Care Settings
9.2.3. Hospitals
9.2.4. Research Laboratories
Chapter 10. Point of Care Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Point of Care Diagnostics Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.2.3. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.2.4. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.5. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.2.6. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.3. Europe
10.3.1. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.3.3. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.3.4. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.5. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.3.6. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.4.3. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.4.4. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.4.5. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts By Sample Type, 2021-2034
10.4.6. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.5. Latin America
10.5.1. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.5.3. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.5.4. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.5. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.5.6. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.6.3. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2021-2034
10.6.4. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.5. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
10.6.6. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Dickinson, And Company (Bd)
11.2.3. Chembio Diagnostic Systems, Inc.
11.2.4. Danaher Corporation
11.2.5. Ekf Diagnostics Holdings Plc
11.2.6. Werfenlife, S.A.
11.2.7. Johnson & Johnson Services, Inc.
11.2.8. Nova Biomedical
11.2.9. Hoffmann-La Roche Ltd.
11.2.10. Sekisui Chemical Co. Ltd.
11.2.11. Quidel Corporation
11.2.12. Siemens Ag
11.2.13. Trinity Biotech
11.2.14. Accubiotech Co., Ltd.
11.2.15. Other Key Players.
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.